Solara Pharma Turns Profitable in Q1

  Published 10 months ago

Solara shares jump 5% as Q1 net profit hits ₹105.2M, reversing loss; expenses drop offset revenue decline.

  • Total expenses fell 18%, helping counter a 12.2% revenue dip and return to profitability from a year-ago loss.
  • Stock eyes seventh weekly gain; over 690K shares traded, 2.2x the 30-day average, most in a month.
  • YTD performance is modest, up 2%, but momentum is building on improving financials and strong trading volume.

You might like these

China's Exports Slow, Deflation Worsens Amid U.S. Tariffs

Sensex, Nifty Rebound on Fed Cut Hopes

Poonawalla Fincorp Leverages AI for Growth

Shimona Chadha Joins Persistent as Global Marketing Leader

SEBI to Standardize Index Derivative Expiries

TVS, Eicher Gain on Q1 Beat, Outlook

Shree Digvijay Eyes Hi-Bond Deal

News that matters the most ⚡